Cyclosporine before PCI in Patients with Acute Myocardial Infarction. - Wikidata - wikimedia - TriplyDB

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

http://www.wikidata.org/entity/Q34491582

about

Ca2+ toxicity and mitochondrial damage in acute pancreatitis: translational overview The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection Reducing myocardial infarct size: challenges and future opportunities Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery Cardioprotection: Where to from here?Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty.Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts.Imaging of Myocardial Ischemia-Reperfusion Injury Using Sodium [18F]Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans.Pharmacological postconditioning with atorvastatin calcium attenuates myocardial ischemia/reperfusion injury in diabetic rats by phosphorylating GSK3β.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!Succinate metabolism: a new therapeutic target for myocardial reperfusion injury.Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria.Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic / Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning.Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside Possible Role of Interaction between PPARα and Cyclophilin D in Cardioprotection of AMPK against In Vivo Ischemia-Reperfusion in Rats Novel targets for mitochondrial medicine.Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion Injury.Harnessing the early post-injury inflammatory responses for cardiac regeneration.Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.The application of remote ischemic conditioning in cardiac surgery Adverse Remodeling and Reverse Remodeling After Myocardial Infarction.Nanoparticle delivery of mitoprotective agents to target ischemic heart disease.Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS Trial - pharmacological reasons for failure.The year in cardiology 2015: acute coronary syndromes.Percutaneous Coronary Intervention: 2015 in Review.Moving Forwards by Blocking Back-Flow: The Yin and Yang of MI Therapy.Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.Novel cardioprotective and regenerative therapies in acute myocardial infarction: a review of recent and ongoing clinical trials.The in vivo evidence for regulated necrosis.Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling.Cellular recruitment in myocardial ischaemia/reperfusion injury.

P2860

Q26744695-3FDD24E5-5735-4B46-89B1-88498F1BBE50 Q26747310-26C129F9-D753-4CAF-9B0A-676DA32BD917 Q26750797-672046F9-9F38-4BAA-9049-BAB01246EEF5 Q26775395-332844E5-38CD-4D58-ACB6-3D6DCA4EA24A Q27350484-96007124-4DB9-4AB6-BD5A-1B308F7E05C3 Q28072918-8B8CD4DB-CFB7-4D99-9626-D2D79F359034 Q30244797-C4A9FE07-CFD2-4159-BF54-F874E6D04F78 Q33645924-A9100F59-E54D-49AF-BB2E-DFA1049E69FD Q33705404-F8E7D9E0-93C4-472A-B43C-F4023C4B74D9 Q33795434-C68ED056-2B00-4BE4-9660-D0A9E63925B0 Q33846404-AB9FED1A-6D86-4AA9-90D7-CE800D06DA16 Q33852943-94B82977-1490-4043-BCD5-217C326386F9 Q34499610-BE55D587-840D-4B23-9FE0-430D09B38343 Q34527213-1993FFF5-B507-41DD-B63E-4C40115A8EF0 Q36091469-99D44722-16CE-4C61-829A-27F0E2E59861 Q36203942-EAD5D903-2CBA-44CE-9C82-9175F576C493 Q36209994-D617DAD9-2EFF-4171-8A97-25F140141045 Q36371672-0104C2D9-C129-468C-A586-06343EDAFF27 Q36712777-5ABB1E4B-CCF8-4D7B-9BC6-DE3EA673F026 Q36761332-9C76A896-7A9D-437C-A957-1AA2EA47AC72 Q37081749-4CBC1E1A-4621-49AB-BA7D-B5D288F17142 Q37127457-5E52A03E-2876-4CBA-BC82-57E1A6E29E83 Q37364465-23E10677-396F-4E1D-B987-10B31940E2F2 Q37586444-24D9A740-DABA-4437-988A-6F72409D8AB2 Q37738596-DBC4A3BF-B706-4C4E-A0B3-2ADC70114961 Q38626782-19A2CFD5-7794-4E56-9FBF-831C811DB511 Q38631258-DAA01676-3FEC-48D7-8340-CB90AFDEF99E Q38660549-ADFAB6CC-024D-4AB3-84B4-E6220041CD94 Q38665321-C4E01A82-BEE0-48AE-92F4-6EBB4573D15E Q38676283-822ADB6E-59EF-472A-8E4F-9BF32B44C596 Q38678061-335E7EA1-6C2C-4B67-82BB-B4DA91E0B377 Q38682136-84D4A920-1BA3-42A6-889E-27ABD208E882 Q38685680-AE04F34C-C372-44EE-A815-424828B8C11F Q38728869-F50F5EF5-CFA6-4A38-B7F2-B161DB98E586 Q38760245-856016CF-9323-4180-B7EE-8BB451DC15D2 Q38762240-A45979A9-69FA-4196-A8AB-7E8B9A0E8F92 Q38801590-BE243CC7-A213-4BAB-98B2-8AC1F1102C45 Q38809791-DA2D7F43-8009-41B6-BDD9-D8D72389DA4D Q38811003-0B38A8EE-31BE-4D0B-BCFB-6FBA64B812EB Q38811208-6A11A3EC-4ACF-49E1-BCBC-B66BB5374016

P2860

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

http://www.wikidata.org/entity/Q34491582

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@ast

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@en

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@nl

type

label

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@ast

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@en

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@nl

prefLabel

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@ast

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@en

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@nl

P1433

Q34491582-A8F316DE-B389-4A0E-89BC-A3C86E9060A5

P1476

Q34491582-227DE4A3-80F9-4960-8BD0-DECF2DCB782B

P2093

Q34491582-0E197FB1-5682-4D23-BF2C-13D65D236ED2

Q34491582-121F178A-121D-4682-9161-F2EE49CDE1B5

Q34491582-216A2B94-7D99-46E2-AABE-5ECAD1980535

Q34491582-2897DA2B-5C33-4072-99DC-05157BC4CF87

Q34491582-2A680D02-EFD5-418C-A57F-28DCB7EBA525

Q34491582-2E0F64F0-0DA6-451E-BFB1-8116E66E67C9

Q34491582-37F24637-1802-423E-9475-2E18507791E3

Q34491582-38248F68-2179-4FF3-8DF6-85E71749C9A1

Q34491582-395DCC0A-DEF8-44B8-A6D0-EDFC65923ADF

Q34491582-423B6BCB-F2D6-4945-BE19-38A5D9F728FD

P304

Q34491582-C112DD96-03FE-41FB-9968-2739AB3FF4C4

P31

Q34491582-F83D8D8F-9E54-4B6B-B873-0FA0DAADCF9C

P356

Q34491582-76AB96AC-B56D-4EFD-90F2-E08854963852

P407

Q34491582-2538FD6D-095F-4FAE-B957-FD181B4A8ED3

P433

Q34491582-28EC8C73-5D9D-4815-A82E-019C588EFC0D

P478

Q34491582-D4FF4696-7066-4CD2-8E6C-F26C35144D44

P50

Q34491582-055C594F-A69F-4DAF-A7C7-9F5693E18EC8

Q34491582-151DAFB4-53A3-4F21-B997-2865C6B68A84

Q34491582-17731538-178E-4501-AECB-0BE2032535F3

Q34491582-B831955F-E0B0-4236-99DA-2F993E956596

Q34491582-BA9D4EDB-1229-4525-BBC3-91189700A270

Q34491582-DCEA153C-2AAD-4CAF-BBAD-0AA9182BF5AA

Q34491582-E5837374-3E1C-45B7-B7CD-F55FCA90B99D

Q34491582-E673E885-6F79-444A-9C0E-35368255053D

P577

Q34491582-D21C0582-CC56-48D4-871A-216B4BCC6AC8

P5875

Q34491582-8DCB905C-B590-4726-ADBC-5098D3316611

P698

Q34491582-BEC10146-4FBC-4A3B-8676-EFDC83629E09

P921

Q34491582-AEC3F320-37DC-4FEA-B828-B662499D0BD6

P356

P1433

The New England Journal of Medicine

P1476

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

@en

P2093

Arnaud Sudre

http://www.w3.org/2001/XMLSchema#string

Bernard Jouve

http://www.w3.org/2001/XMLSchema#string

Christophe Tron

http://www.w3.org/2001/XMLSchema#string

Claire Jossan

http://www.w3.org/2001/XMLSchema#string

Cyrille Bergerot

http://www.w3.org/2001/XMLSchema#string

David Garcia-Dorado

http://www.w3.org/2001/XMLSchema#string

Didier Blanchard

http://www.w3.org/2001/XMLSchema#string

Eric Bonnefoy-Cudraz

http://www.w3.org/2001/XMLSchema#string

Eskil Elmer

http://www.w3.org/2001/XMLSchema#string

Fabien De Poli

http://www.w3.org/2001/XMLSchema#string

P304

1021-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1505489

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

373

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Gabriel Steg

Geneviève Derumeaux

Jean-Luc Dubois-Randé

Denis Angoulvant

Christophe Piot

Marie-Claude Morice

Guillaume Cayla

P577

2015-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281394673

http://www.w3.org/2001/XMLSchema#string

P698

26321103

http://www.w3.org/2001/XMLSchema#string

P921